Please assess the completion status of the following clinical trial:

Trial Title: A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of moderate to severe ARDS, as defined by the Berlin definition, requiring an endotracheal or tracheal tube~* Able to receive investigational medicinal product within 96 hours of meeting the last of the ARDS diagnosis criterion~Exclusion Criteria:~* Concurrent illness that shortens life expectancy to less than 6 months~* Other serious medical or psychiatric illness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Cohort 1 (Type: EXPERIMENTAL): Low dose MultiStem
- Cohort 2 (Type: EXPERIMENTAL): High dose MultiStem
- Cohort 3 (Type: EXPERIMENTAL): Highest safe MultiStem dose (from Cohorts 1 and 2) or Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).